Pierre Sonigo

This inventor holds 63 USPTO granted patents, plus 7 CIPO patents and 2 EPO patents, primarily in HIV Molecular Biology (CPC class 5303). Top assignees: Institut Pasteur, Centre National De La Recherche Scientifique, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 1991-2013.

USPTO Granted Patents = 63

% Patents Active = 88.9

CIPO Patents = 7

EPO Patents = 2

Average Co-Inventor Count = 5.4

ph-index = 10

Forward Citations = 344(Granted Patents)

Forward Citations (Not Self Cited) = 291(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Gutenberg, FR (2005)
Paris, FR (1991 - 2013)

Company Filing History:

Centre National De La Recherche Scientifique

patents

2 out of 3,688

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

4. 1 out of 1,853

National Institute of Health and Medical Research

patents

5. 4 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 1991-2013

Loading Chart...

Areas of Expertise:

HIV-1

HIV-2

Nucleic Acid

Peptides

Diagnostic Assays

Cloned DNA Sequences

Antibodies

RNA

Viral Extracts

LAV Virus

Genomic RNA

Polypeptides

63 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8507196 - Nucleic acid probe of human immunodeficiency virus type 1 (HIV-1), and a method and kit employing this probe for detecting the presence of nucleic acid of HIV-1 (2013-08-13),

2. 8329396 - Cloned DNA sequences hybridizable with genomic RNA of lymphadenopathy associated virus (LAV) (2012-12-11),

3. 7767800 - [object Object] (2010-08-03),

4. 7626013 - HIV-1 DNA fragments that hybridize to genomic HIV-1DNA (2009-12-01),

5. 7585619 - Method for detecting human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) activity (2009-09-08),

6. 7351412 - Cloned DNA sequences related to the genomic RNA of lymphadenopathy-associated-virus (LAV) and proteins encoded by said LAV genomic RNA (2008-04-01),

7. 7341731 - HIV-2 antigen compositions (2008-03-11),

8. 7232654 - DNA sequence of the LTR region of human immunodeficiency virus type 1 (HIV-1) (2007-06-19),

9. 7217508 - Cloned DNA sequence related to genomic RNA of human immunodeficiency virus (HIV-1) (2007-05-15),

10. 7119181 - DNA sequences and peptides of human immunodeficiency virus (HIV-1) (2006-10-10),

11. 7115363 - Retrovirus capable of causing AIDS, means and methods for detecting it in vitro (2006-10-03),

12. 7045130 - Antibodies against antigens of human immunodeficiency virus (HIV-1) (2006-05-16),

13. 7029679 - Variant of LAV viruses (2006-04-18),

14. 6979535 - Human immunodeficiency virus type 2 (HIV-2) env polypeptide and diagnostic assays (2005-12-27),

15. 6951648 - Variant of LAV viruses (2005-10-04),

Title: Inventor Pierre Sonigo - Revolutionizing Technology in Paris

Introduction: Pierre Sonigo is a visionary inventor based in Paris, France, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Pierre Sonigo holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, Pierre Sonigo has worked with leading research institutions and tech companies to develop cutting-edge solutions that have had a significant impact on various industries.

Collaborations: Throughout his career, Pierre Sonigo has collaborated with top scientists, engineers, and researchers from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: Pierre Sonigo's relentless pursuit of innovation and his passion for pushing the boundaries of technology make him a true pioneer in the field, inspiring the next generation of inventors and entrepreneurs.